Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02795455 · ClinicalTrials.gov registry record · NA
Reward Systems and Food Avoidance in Eating Disorders
A NA study of Anorexia Nervosa and Low Weight Eating Disorders, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
- 1
- Study location
NCT02795455: Completed NA study of Anorexia Nervosa and Low Weight Eating Disorders, sponsored by Icahn School of Medicine at Mount Sinai.
NCT02795455 is a NA study of Anorexia Nervosa and Low Weight Eating Disorders that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 90 participants, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02795455, a NA study of Anorexia Nervosa and Low Weight Eating Disorders, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
- 1
- Study location
Study Summary
The researchers plan to explore brain networks involved in emotion processing and learning using a brain scan and test meals. One core feature of Anorexia Nervosa (AN) is eating a small number of high-calorie or high-fat foods. By studying why individuals with AN are disgusted by food or other eating situations, the researchers will be able to understand more about the neurobiological pathways that lead to restricting food intake and food avoidance. This study also aims to find whether one of two short-term interventions (Interoceptive Exposure (IE); Family-Based Therapy (FBT)) affects connections in the brain and if the treatments affect food avoidance. IE is an intervention that helps reduce anxiety about eating. FBT is an intervention that motivates patients to eat through working with family to increase the value of eating and decrease the value of avoiding foods.
Primary Outcome
Change in the emotional responses from facial muscle movements to food pictures and non-food pictures as measured with the fMRI-EMG.
Conditions Studied
Interventions
- BEHAVIORAL Interoceptive Exposure (IE)
- BEHAVIORAL Family Based Therapy-Weight Gain Control (FBT-WG)
- DIETARY_SUPPLEMENT meal replacement shake
Study Locations (1)
New York
- Icahn School of Medicine at Mount Sinai - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2016-11 |
| Est. Completion | 2021-07-29 |
| Phase | NA |
What the finished NCT02795455 record still lists
NCT02795455 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 90 participants, a relatively small participant target, below the 948-participant average among 43 other Anorexia Nervosa trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Anorexia Nervosa appearing as the primary indexed condition, and to 3 interventions - of which Interoceptive Exposure (IE) is the first listed.
NCT02795455 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02795455 about?
NCT02795455 is a clinical study titled "Reward Systems and Food Avoidance in Eating Disorders". The researchers plan to explore brain networks involved in emotion processing and learning using a brain scan and test meals. One core feature of Anorexia Nervosa (AN) is eating a small number of high-calorie or high-fat foods. By studying why individuals with AN are disgusted by food or other eatin...
What is the current status of trial NCT02795455?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2016-11. Estimated completion is 2021-07-29.
What conditions does trial NCT02795455 study?
This clinical trial studies the following conditions: Anorexia Nervosa, Low Weight Eating Disorders.
What interventions are being tested in trial NCT02795455?
The interventions under investigation include: Interoceptive Exposure (IE) (BEHAVIORAL), Family Based Therapy-Weight Gain Control (FBT-WG) (BEHAVIORAL), meal replacement shake (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02795455?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02795455 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anorexia Nervosa
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02795455's enrollment target sits among peer trials
90 11th of 43 higher than 31 of 43 other Anorexia Nervosa trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anorexia Nervosa trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Diet for Relapse Prevention in Anorexia Nervosa
RECRUITING · NA
-
Facing Eating Disorder Fears for Anorexia Nervosa
RECRUITING · NA
-
Therapeutic Ketogenic Diet in Anorexia Nervosa
RECRUITING · NA
-
Confirming the Effectiveness of Online Guided Self-Help Family-Based Treatment for Adolescent Anorexia Nervosa
RECRUITING · NA
-
Targeting Social Function in Anxiety and Eating Disorders
RECRUITING · NA
-
Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia